The World Health Organisation (WHO) has called on the Government to intensify fight against substandard and counterfeit medical products.
 A report released yesterday by WHO indicates that at least 10 per cent of drugs circulating in low and middle-income countries is either substandard or falsified. 
 ALSO READ:

WHO revokes appointment of Mugabe as goodwill ambassador

 Substandard medicines expose the public to serious illnesses and can cause unnecessary deaths.
 WHO Director General Dr Tedros Adhanom has called on partner countries to step up the fight against the fake products.




(adsbygoogle = window.adsbygoogle || []).push({});

 “Substandard and falsified medicines, particularly affect the most vulnerable communities. It is unfortunate that innocent people continue to die as a result of using substandard or falsified medicines. It is time all countries take action against this issue,” said Dr Tedros Adhanom.
 The Pharmacy and Poisons Board (PPB) had in September established a Sh300 million post-market surveillance laboratory to track the safety, efficiency and quality of drugs in the Kenyan market.
 The Government established several other mini-labs in Nairobi, Mombasa, Kakamega, Kisumu, Migori, Kericho, Kisii, Eldoret, Kajiado, Kwale and Busia counties where these drugs are most common.
